(Q64942454)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L-DOPA (English)

1 reference

19 January 2024

main subject

parkinsonian syndrome

1 reference

B. Johansson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5151306

19 January 2024

B. E. Roos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5151306

19 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5151306

19 January 2024

publication date

1 September 1971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 October 2019

http://link.springer.com/content/pdf/10.1007/BF00565012.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00565012/fulltext.html

19 January 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF00565012

19 January 2024

1 reference

European Journal of Clinical Pharmacology

19 January 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

232-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5151306%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00565012

13 October 2019

exact match

0 references

cites work

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

1 reference

12 December 2020

Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission

1 reference

12 December 2020

Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?

1 reference

12 December 2020

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

1 reference

12 December 2020

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

1 reference

12 December 2020

Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease

1 reference

12 December 2020

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

1 reference

12 December 2020

Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.

1 reference

12 December 2020

Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using th

1 reference

12 December 2020

EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM

1 reference

12 December 2020

Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients

1 reference

12 December 2020

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

12 December 2020

5-Hydroxyindoleacetic Acid in Ventricular Cerebrospinal Fluid and Brain of Normal and Hydrocephalic Dogs after Administration of 5-Hydroxytryptophan. II

1 reference

12 December 2020

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

1 reference

12 December 2020

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

12 December 2020

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

1 reference

12 December 2020

Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex

1 reference

12 December 2020

Tryptophan in the treatment of depression.

1 reference

12 December 2020

Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide

1 reference

12 December 2020

Depressed Monoamine Catabolite Levels in Cerebrospinal Fluid of Patients with Parkinsonism Dementia of Guam

1 reference

12 December 2020

Evidence for a central noradrenaline receptor stimulation by clonidine.

1 reference

12 December 2020

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism

1 reference

12 December 2020

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

1 reference

12 December 2020

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

1 reference

12 December 2020

Oral L-dopa treatment of parkinsonism.

1 reference

12 December 2020

5-Hydroxyindoles in Human Cerebrospinal Fluids

1 reference

12 December 2020

1 reference

12 December 2020

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

1 reference

12 December 2020

1 reference

12 December 2020

Studies of the monoamine metabolism in the central nervous system in Jakob-Creutzfeldt disease.

10

1 reference

Aromatic Amino Acids and Modification of Parkinsonism

19 January 2024

16

1 reference

Morphological and Functional Aspects of Central Monoamine Neurons

19 January 2024

22

1 reference